Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season
Clinical trial NCT03158038 · COMPLETED
Trial details
- NCT number
- NCT03158038
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-30
- Primary completion
- 2017-12-14
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.